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Abstract
Background: Dengue, one of the most important arboviral diseases of humans, may cause severe systemic
disease. Although dengue virus (DENV) has been considered to be a non-neurotropic virus, dengue infection has
been associated recently with a series of neurological syndromes, including encephalitis. In this work, we evaluated
behavioral changes and inflammatory parameters in C57BL/6 mice infected with non-adapted dengue virus 3
(DENV-3) genotype I.
Methods: C57BL/6 mice received 4 × 10
3 PFU of DENV-3 by an intracranial route. We evaluated the trafficking of
leukocytes in brain microvasculature using intravital microscopy, and evaluated chemokine and cytokine profiling
by an ELISA test at 3 and 6 days post infection (p.i.). Furthermore, we determined myeloperoxidase activity and
immune cell populations, and also performed histopathological analysis and immunostaining for the virus in brain
tissue.
Results: All animals developed signs of encephalitis and died by day 8 p.i. Motor behavior and muscle tone and
strength parameters declined at day 7 p.i. We observed increased leukocyte rolling and adhesion in brain
microvasculature of infected mice at days 3 and 6 p.i. The infection was followed by significant increases in IFN-g,
TNF-a, CCL2, CCL5, CXCL1, and CXCL2. Histological analysis showed evidence of meningoencephalitis and reactive
gliosis. Increased numbers of neutrophils, CD4
+ and CD8
+ T cells were detected in brain of infected animals,
notably at day 6 p.i. Cells immunoreactive for anti-NS-3 were visualized throughout the brain.
Conclusion: Intracerebral infection with non-adapted DENV-3 induces encephalitis and behavioral changes that
precede lethality in mice.
Background
Dengue, one of the most important arboviral human
diseases, is a serious cause of morbidity and mortality in
tropical and subtropical regions of the world. Approxi-
mately 2.5 billion people are at risk of being infected by
dengue virus [1]. The dengue virus (DENV) comprises
four serotypes - DENV-1, DENV-2, DENV-3, and
DENV-4, all of which appear to be present in 22 of the
27 states of Brazil [2-4].
Although DENV has been considered a non-neurotro-
pic virus in humans, some authors have described the
presence of the virus in cerebrospinal fluid (CSF), and
dengue antigens in brain tissue [5,6]. Moreover, infection
has been associated with encephalitis, acute disseminated
encephalomyelitis, neuropathies, and Guillain-Barré
syndrome [6-8]. Therefore, dengue infection should be
considered as a possible cause of encephalitis in endemic
regions [6]. Patients with dengue encephalitis can present
headache, neck stiffness, intermittent tremors, altered
consciousness, abnormal coordination, convulsions, and
coma [5,6].
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pathogenesis and progression of the disease. The use of
animal models has been relevant to mimic viral encepha-
litis and to provide mechanisms for comprehension of its
pathogenesis [9]. To study the immune response elicited
specifically in the CNS compartment and to prevent the
spurious influence of the peripheral immune system, it is
necessary to use an intracranial route, i.e. to inoculate
the virus directly in the brain. We have previously evalu-
ated the immune response in a model of severe Herpes
simplex virus type 1 (HSV-1) encephalitis determined by
intracerebral inoculation of the virus [10,11]. Interest-
ingly enough, we have demonstrated a differential role
for TNFR1 in HSV-1 infection depending on the route of
viral inoculation. While TNFR1 seems to play a relevant
role in control of viral replication in the CNS when HSV-
1 is inoculated by the intracranial route, TNF-a seems to
protect against encephalitis by a mechanism independent
of TNFR1 when HSV-1 is inoculated in the periphery
[12]. Metalloproteinases (MMP) have also been involved
in the development of HSV-1 encephalitis by causing
damage to the cerebral vasculature and, hence, favoring
transmigration of leukocytes and CNS damage [13].
I nt h ep r e s e n tw o r k ,w ea i m e dt os t u d yb e h a v i o r a l
symptoms, leukocyte traffic, and inflammatory para-
meters in the brain of C57BL/6 mice infected with a
non-adapted human DENV-3 genotype I.
Methods
Virus
Viral isolation was performed as described elsewhere [2].
Briefly, 50 μL of a serum sample from a single human
patient was incubated with C6/36 cells, and at least
three successive passages were conducted for each sam-
ple. Microscopic examination of cells inoculated with
patient serum showed a clearly visible cytopathic effect
with changes in the monolayer such as syncytial cell for-
mation and cytoplasmic vacuoles after the third passage.
Supernatants of infected C6/36 cells that showed a typi-
cal cytopathic effect were centrifuged at 1680 × g for
15 min at 4°C. The supernatants were collected, divided
in 0.3-mL aliquots and stored at -70°C until use.
Mice and animal care
Male C57BL/6 mice, ages 6-9 weeks, were obtained
from the Animal Care Facilities of the Institute of Biolo-
gical Sciences, Federal University of Minas Gerais (ICB-
UFMG), Belo Horizonte, Brazil. The Animal Ethics
Committee of UFMG approved all experimental proce-
dures used in the present study.
Infection with non-adapted DENV-3
For DENV infection, mice were handled and kept in a
biosafety level 2 (BSL-2) facility. To induce encephalitis,
anesthetized C57BL/6 mice were inoculated intracra-
nially with 4 × 10
3 plaque-forming units (PFU) of the
purified DENV-3 genotype I resuspended in 20 μLo f
phosphate-buffered saline (PBS). Sham animals were
injected intracranially with 20 μL of PBS only. The capa-
city of this inoculum to induce more evident neurologi-
cal signs and meningoencephalitis than lower doses has
been evaluated previously [14]. After infection, the clini-
cal signs and mortality were observed daily.
Quantification of virus in brain of DENV-3 infected mice
Viral quantification in infected mice was performed as
previously described [14]. Briefly, the brains were har-
vested, weighed, homogenized, and microcentrifuged
(10 min, 4°C, 6000 × g) to pellet the cell debris. LLC-
MK2 cells were cultured overnight in 24-well plates
before the media were removed and 0.5 mL of serial sam-
ple dilutions (10-fold) were added to individual wells.
Plates were incubated for 1 h before media were aspi-
rated and replaced with 0.5 mL of 0.8% methyl-cellulose
medium (with 2% FBS). Plates were then incubated for
7 days before the media were removed and the cells were
fixed in 4% formaldehyde for 20 min, rinsed in water,
stained with crystal violet for 20 min, and rinsed again.
Plaques were counted visually, and the concentrations of
plaque-forming units per mL (PFU/mL) were calculated.
SHIRPA screen
Behavioral and functional parameters were evaluated using
a screening battery called SmithKline/Harwell/Imperial
College/Royal Hospital/Phenotype Assessment (SHIRPA)
[15,16]. After a period of mouse adaptation, the procedure
was carried out from day 2 until day 7. For the purpose of
analysis, the individual parameters assessed by SHIRPA
were grouped into five functional categories (neuropsychia-
tric state, motor behavior, autonomic function, muscle
tone and strength, and reflex and sensory function) [15,16].
Intravital microscopy
Intravital microscopy of the mouse brain microvasculature
was carried out as routinely performed in our laboratory
[10]. Briefly, mice were anesthetized by intraperitoneal
injection of a mixture of ketamine (150 mg/Kg) and xyla-
zine (10 mg/Kg), and the tail vein was cannulated for
administration of fluorescent dyes. A craniotomy was per-
formed using a high-speed drill and the dura mater was
removed to expose the underlying pial vasculature.
Throughout the experiment, mice were maintained at
37°C with a heating pad and the exposed brain was
continuously superfused with an artificial cerebrospinal
fluid buffer with ionic mmol/L composition of NaCl 132,
KCl 1.95, CaCl2 1.71, MgCl2 0.64, NaHCO3 24.6, dextrose
3.71, and urea 6.7, pH 7.4, at 37°C.
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administration of Rhodamine 6G- Sigma (0.5 mg/kg body
weight) and were observed using a microscope (Olympus
B201, x20 objective lens, corresponding to 100 μmo f
area) outfitted with a fluorescent light source (epi-
illumination at 510-560 nm, using a 590-nm emission
filter). The number of rolling and adherent leukocytes
was determined offline during video playback analysis.
Leukocytes were considered adherent to the venular
endothelium if they remained stationary for a minimum
of 30 s. Rolling leukocytes were defined as white cells
moving at a velocity lower than that of erythrocytes
within a given vessel. Pial vessels with diameters ranging
from 50 to 120 μm were used, as most adhesion occurred
in vessels in this size range. Leukocyte adhesion was
expressed as the number of cells/100 μm.
Histopathology and immunohistochemistry
Brains from control and infected mice were collected at
days 3 and 6 p.i. and preserved in 10% buffered forma-
lin. Sections of 5 μm thickness were cut at intervals of
10 μm and mounted for hematoxylin and eosin staining.
For immunohistochemistry, sections were treated with
3% H2O2 diluted in Tris-buffered saline (TBS) (pH 7.4)
for 30 minutes. For antigen retrieval, tissue sections
were immersed in citrate buffer (pH 6.0) for 20 minutes
at 95°C. For detection of DENV-3-infected cells an anti-
NS3 MAb E1D8 was used in a dilution of 1:200; at 4°C
overnight. After incubation, tissue sections were washed
with TBS and treated with a labeled streptavidin-biotin
kit EnVision
® + Dual Link System-HRP (Dako). Sections
were then rinsed in PBS with 3,3’-diaminobenzidine tet-
rahydrochloride (K3468, Dako) for 5 minutes and
stained with Mayer’s hematoxylin. Negative controls
were obtained by the omission of primary antibodies,
which were substituted by 1% PBS-TBS.
Histopathological analysis and scoring were performed
in cerebral cortex, cerebellum, hippocampus and brain-
stem. Each area of the brain was graded on a 0 to
4-point scale: 0 = no pathology; 1 = minimal tissue
destruction and/or mild inflammation/gliosis; 2 = mild
tissue destruction and/or moderate inflammation/gliosis;
3 = definite tissue destruction (neuronal loss, parenchy-
mal damage) and intense inflammation; 4 = necrosis
(complete loss of all tissue elements with associated cel-
lular debris. Meningeal inflammation was assessed and
graded as follows: 0 = no inflammation; 1 = one cell
layer of inflammation; 2 = two cell layers of inflamma-
tion; 3 = three cell layers of inflammation; 4 = four or
more cell layers of inflammation [10,17]. The density of
necrotic or apoptotic neurons was assessed as not
detectable (no cell damage: 0), minimal (<10% of all
cells: 1), moderate (10-30% of all cells: 2), and numerous
(>30% of all cells: 3) [18].
ELISA of proteins in cerebral tissue
Brain tissue extracts were obtained from control and
infected mice and stored at -20°C. Thereafter, the brain
tissue was homogenized in an extraction solution (100 mg
of tissue per 1 mL of extraction solution) containing
0.4 mol/L NaCl, 0.05% Tween 20, 0.5% BSA, 0.1 mmol/L
phenylmethyl sulfonil fluoride, 0.1 mmol/L benzethonium
chloride, 10 mmol/L EDTA, and 20 KI aprotinin, using
Ultra-Turrax (Fisher Scientific, Pittsburgh, PA). The brain
homogenate was centrifuged at 3000 × g for 10 min at
4°C, and the supernatant was collected and stored at
-20°C. Concentrations of the cytokines IFN-g and TNF-a,
and of the chemokines CCL2, CCL5, CXCL1, and CXCL2
were determined using ELISA. The brain tissue superna-
tants were assayed in an ELISA setup using commercially
available antibodies, according to the manufacturer’s
procedures (R&D Systems, Minneapolis, MN).
Tissue extraction and determination of myeloperoxidase
(MPO) activity
Tissue extraction and determination of MPO activity
were performed. After processing the tissues, the pellet
was weighed, homogenized in 2.5 mL of buffered saline
EDTA-sodium phosphate-HCl, pH 4.7 (0.1 M NaCl,
0.02 M Na3PO4, 0.015 M Na2EDTA), and centrifuged at
3000 × g at 4°C for 15 min. The pellets were then resus-
pended in 2.5 mL of 0.05 M sodium phosphate buffer
pH 5.4 containing 0.5% hexa-1,6-bis-decyltrimethylam-
monium bromide (HTAB, Sigma). The suspensions
were freeze-thawed three times using liquid nitrogen
and finally centrifuged at 3000 × g at 4°C for 15 min.
MPO activity in the resulting supernatant was assayed
by mixing 25 μLo f3 , 3 ’,5,5’-tetramethylbenzidine (TMB,
Sigma) prepared in dimethyl sulfoxide (DMSO, Merck)
at a final concentration of 1.6 mM with 100 μLo f
0.003% (v/v)H 2O2, dissolved in 0.05 M sodium phos-
phate buffer pH 5.4 and 25 μL of the supernatants from
tissue sample processing. The assay was carried out in a
96-well microplate and was started by incubating the
supernatant sample and the TMB solution (25 μL) for
5 min at 37 °C. Then, H2O2 was added and the incubation
continued for another 5 min. The reaction was terminated
by adding 100 μL4MH 2SO4 and was quantified colori-
metrically at 450 nm in a spectrophotometer (E max-
Molecular Devices). Results are expressed as change in
OD per gram of wet tissue (implant).
Flow cytometry and cell sorting
Mice were infected intracranially with 4 × 10
3 PFU of
DENV-3 as described. On day s3a n d6p o s ti n f e c t i o n ,
mice were anesthetized and perfused intracardially with
PBS to remove both circulating and non-adherent RBCs
and leukocytes from the brain. Brains were removed
and adherent leukocytes isolated using a previously
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sample (n) corresponds to a pool of 2-3 mice brains.
Briefly, the brains were collected and homogenized
gently using a sterile glass tissue grinder in RPMI 1640
medium containing 5% FCS. Homogenates were passed
through a nylon cell strainer (70 μm; Becton Dickinson
and Company, Brazil) and cells centrifuged at 400 × g for
10 minutes. The pellet was resuspended on a 35% Percoll
gradient (Sigma-Aldrich) and this deposited gently on a
70% Percoll gradient. After centrifugation (1100 × g), the
leukocytes were collected at the boundary layer, resus-
pended in FACS buffer (PBS containing 1% FCS and
0.01% NaN3) and counted. Brain-sequestered cells were
stained for extracellular molecular expression patterns
using monoclonal antibodies (mAb) against mouse CD3e
conjugated to phycoerythrin (PE) (BD Pharmingen San
Diego, CA; clone 17A2), CD4 to fluorescein isothiocyante
(FITC) (BD Pharmingen San Diego, CA; clone L3T4),
CD8a conjugated to Peridinin Chlorophyll Protein
Complex (PerCP) (BioLegend; clone 53-6.7) for Mix 1, or
Ly-6G conjugated to fluorescein isothiocyante (FITC)
(eBioscience; clone RB6-8C5), CD11b conjugated to PE-
Cy5 (BioLegend; clone M1/70) for Mix 2 and isotype
controls (all from BD Pharmingen San Diego, CA). For
each sample, 20000 cells from the lymphocyte population
were scored. The frequency of positive cells was analyzed
using a gate that included lymphocytes and granulocytes.
Limits for the quadrant markers were always set based
on negative populations and isotype controls. Cells were
acquired on a FACS Calibur flow cytometer (BD Bios-
ciences) and analyzed using FlowJo 7.5.3 software (Tree-
Star Inc.). Analysis in FlowJo software took into account
size (forward light scatter) and granularity (side light
scatter) of populations. Frequency in number of an ana-
lyzed population in front of total acquired events was
used in the construction of graphs.
Statistical analysis
Data are shown as mean ± SEM. The Kaplan-Meier test
was employed to compare survival rates. One-way
ANOVA with Tukey’s correction was used for multiple
comparisons. Statistical significance was set at p < 0.05.
Results
Effects of non-adapted human DENV-3 on disease
symptoms and mouse survival following intracranial
inoculation
Following intracranial infection with DENV-3 genotype
I, animals presented neurological symptoms of apathy,
stereotyped behavior, and seizures. All animals died by
day 8 p.i. (Figure 1).
To better analyze the neurological signs, we performed
the SHIRPA battery of behavioral tests in the animals.
SHIRPA analysis confirmed that infected mice developed
behavioral changes during the course of the disease and
that changes occurred predominantly immediately prior
to death (Figure 2). Motor behavior (p < 0.01) and muscle
tone and strength parameters (p < 0.001) were altered
from day 6 onwards and drastically declined on day 7 p.i.
(Figure 2 A, B).
Quantification of virus in brain of DENV-3 infected mice
Infectious viral titers in mouse brain were determined 3,
5, and 6 days p.i. We could not detect the virus on day
3p . i .O nd a y s5a n d6p . i . ,t h e r ew e r e3×1 0
4 and 4 ×
10
5 PFU/mL, respectively (Table 1).
Leukocyte recruitment is increased in the pial
microvasculature of non-adapted DENV-3 infected mice
Leukocyte-endothelium interactions (rolling and adhe-
sion) were examined in the pia-mater of control and
infected mice. Meningeal vessels of control animals
revealed just a limited number of rolling and adhering
l e u k o c y t e s .A td a y s3a n d6p . i . ,t h en u m b e ro fr o l l i n g
and adherent leukocytes increased significantly in
infected mice (Figure 3A and 3B).
Non-adapted human DENV-3 in infected mice induces
meningoencephalitis in different brain regions
Brains from mice that were given PBS (control) or from
mice that were infected with DENV-3 were removed at
days 3 and 6 p.i. Control animals did not show any his-
tological changes (Figure 4A and 4E). None of the
infected animals presented meningitis at day 3 p.i. How-
ever, mild gliosis and multifocal areas of perivascular
hemorrhages were detected in the brainstem of all ani-
mals. On day 6 p.i., all animals showed diffuse menin-
geal infiltration of neutrophils and mononuclear cells in
cerebrum and cerebellum (Figure 4B). Several perivascu-
lar cuffs of mononuclear cells, numerous rod-shaped
microglial cells (Figure 4C) and vasculitis (Figure 4D)
Figure 1 Time course of survival of mice infected with 4 × 10
3
PFU of DENV-3 by the intracranial route (n = 20). Control
animals (n = 20) received 20 μL of phosphate-buffered saline (PBS).
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hippocampus and brainstem. The hippocampus showed
intense neuronal destruction of the pyramidal layer
from the CA3 and CA2 areas (Figure 4F, Figure 5).
NS3-positive cells were visualized throughout the par-
enchyma from cerebrum, brainstem and cerebellum
(Figure 4G). These cells were mainly located in foci of
tissue inflammation and destruction (Figure 4F).
We compared the extent of brain pathology in
meninges, cortex, brainstem, hippocampus and cerebel-
lum of mice following infection. We used a four-point
scale to evaluate the effect of DENV-3 on encephalitis.
This semi-quantitative analysis demonstrated progressive
pathological changes in the meninges, cerebral cortex,
cerebellum, hippocampus and brainstem (Figure 5).
Cytokine and chemokine levels are increased in brain
tissue from non-adapted DENV-3 infected mice
We evaluated cerebral levels of the cytokines IFN-g and
TNF-a, and of the chemokines CCL2, CCL5, CXCL1, and
CXCL2 (Figure 6). Following DENV-3 infection, early che-
mokine expression is marked mainly by the production of
CXCL2 and CCL2, responsible for attracting neutrophils
and monocytes, respectively. The levels of CCL2 were per-
sistently elevated throughout the course of DENV-3 infec-
tion. After this initial expression, increases in the levels of
CXCL1, CCL5, TNF-a,a n dI F N - g occurred.
Neutrophils are increased in the brains of non-adapted
DENV-3 infected mice
To confirm the presence of neutrophil infiltration in
brains of DENV-3 infected mice, we measured MPO
activity in brain tissue from control and infected mice at
days 3 and 6 p.i. Levels of MPO activity progressively
increased during the course of infection. MPO activity
was significantly lower in control mice when compared
with the infected group (Figure 7).
DENV-3 infection promotes increased levels of
neutrophils and lymphocytes
Fluorescence-activated cell sorting (FACS) analysis was
used to determine the specific immune cell composition
in infected brains, targeting neutrophils, CD4
+ and CD8
+
T-cells (Figure 8). Control mice had fewer CNS inflamma-
tory cells, including neutrophils, CD4
+, and CD8
+ T-cells
compared to infected mice. The brain of infected animals
at day 6 p.i. contained significantly higher numbers of neu-
trophils, characterized as CD11
+ Ly6G
+, compared with
infected mice at day 3 p.i (Figure 8A) (p < 0.001). On day
3 post infection, the number of CD4
+ T-cells was similar
in both groups (control versus infected) (Figure 8B).
Otherwise, the number of CD8
+ T-cells was approximately
four-fold higher among infected mice, compared with con-
trol mice at the same period (Figure 8C). Moreover, we
found that the number of CD4
+ as well as CD8
+ T-cells
was significantly elevated in DENV-3 mice at day 6 p.i. (p
< 0.001 and p < 0.02, respectively).
Discussion
In this study, we found that DENV-3 infected mice
developed lethal encephalitis. Behavioral changes
occurred at the peak of inflammatory changes in the
CNS of infected animals and preceded death. To our
knowledge, behavioral changes associated with leukocyte
trafficking, the population of immune cells recruited
Figure 2 Visualization of performance (SHIRPA test) of control
animals (n = 8) and mice infected with 4 × 10
3 PFU of DENV-3
by the intracranial route (n = 8), from days 2 to 7 of infection.
Motor behavior (A) and muscle tone and strength parameters (B)
showed significant alterations in the infected group at day 7 p.i.
***p < 0.001 and **p < 0.01.
Table 1 Infectious viral titers in brains of dengue virus-
infected C57Bl/6 mice at days 3, 5 and 6 post infection
Days after infection (n = 3) p.f.u./mL
3 not detected
5 3.10
4 ±1 0
4
6 4.10
5 ±1 0
5
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DENV-3 encephalitis have not been previously reported.
In the present model, non-adapted DENV-3 was inocu-
lated by an intracranial route to evaluate the CNS immune
response to the infection. This route allows the study of
viral-associated CNS lesions which are not seen in mice
inoculated by an intraperitoneal route [20]. The observed
CNS lesions were similar to those seen in human dengue
encephalitis [6]. Using a similar approach, we have
demonstrated that the intracranial route allows investiga-
tion of specific immune mechanisms involved in the CNS
response to viral infection which are not evident when
HSV-1 is inoculated in the periphery [12].
Our results also provide evidence of CNS compromise
using a standardized protocol which demonstrated
changes in muscle tone and strength, and motor beha-
vior. Similar neurological deficits have been reported in
patients with dengue infection [5]. We also found that
these behavioral changes occurred after the increase of
the inflammatory response and tissue destruction in
CNS. Furthermore, the infected animals presented neu-
rological symptoms of apathy, stereotyped behavior, and
seizures, characterized by forelimb clonus with rearing
and falling. At day 6 p.i. we observed greater pathologic
brain scores with loss of more than 30% of neurons in
the hippocampus, mainly in the CA3 region. Apoptotic
cell death has been described in several flaviviral infec-
tions, such as dengue viruses, Japanese encephalitis virus
and West Nile Virus (WNV). DENV-2 triggers apoptotic
signaling to kill infected cells and initiate survival signal-
ing to hold the cells in a favorable condition for longer
virus progeny production. Similar pathways could also
be involved in DENV-3 encephalitis [21]. DENV-2 acti-
vates the PI3K/Akt pathway as an antiapoptotic pathway
to protect infected cells from early apoptotic cell death
[22]. Infection with WNV in the CNS causes limbic sei-
zures with participation of IFN-g in the development of
excitatory glutamate receptor-responsive circuits in the
CNS, especially involving the N-methyl-D-aspartate
(NMDA) receptor. NMDA inhibition not only abrogates
limbic seizures, but also prolongs survival of infected
animals. The modulation of these neurological pathways
has not been evaluated here but may have important
implications for patients suffering from dengue encepha-
litis in the clinical setting [23]. Further studies should
investigate this possibility.
DENV-3-infected mice exhibited progressive menin-
goencephalitis characterized by infiltration of neutro-
phils and mononuclear cells. Before migrating to the
brain parenchyma, leukocytes must roll and adhere to
the brain microvasculature [24]. We assessed leukocyte
rolling and adhesion in pia-mater vessels at days 3 and
6 p.i. Leukocyte recruitment was up-regulated in the
microvasculature, leading to increased infiltration of
inflammatory cells into brain tissue. Recruitment of
these cells into the CNS may be the result of chemoat-
traction exerted by increased levels of cytokines and/or
chemokines [10].
CXCL2, a chemokine related to preferential recruit-
ment of neutrophils, was incre a s e da t3a n d6d a y sp . i . ,
indicating the presence of stimulus for leukocyte recruit-
ment during the course of the infection. CXCL2 has
Figure 3 Leukocyte-endothelium interactions visualized using intravital microscopy. Rolling (A) and adhesion (B) of leukocytes in brain
microvasculature were assessed in control mice and in mice infected with 4 × 10
3 PFU of DENV-3 at 3 and 6 days p.i. by the intracranial route.
A higher number of rolling and adhering leukocytes was observed in the microvasculature in brain of infected mice. Data expressed as mean ±
SEM of cells per minute (A) and per 100 μm (B). ***p < 0.001, **p < 0.01, *p < 0.05.
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3 PFU of DENV-3 (n = 4) by
intracranial route, 6 days p.i. Hematoxilin & eosin-stained sections from cerebrum of a control animal with normal histological appearance of
cerebrum (A) and hippocampus (E). Brain sections from a DENV-3-infected animal showing: meningoencephalitis characterized by infiltration of
immune cells in the meninges (open arrow) (B), perivascular cuffing (PC) (C), gliosis (insert) and (D) vasculitis (asterisk). Note intense neuronal
destruction in the pyramidal layer of the CA3 and CA2 areas of the hippocampus (F). Immunohistochemical staining for anti-NS3 protein for
DENV-3 showing immunoreactive cells (arrows) in the cerebellar granular layer (G) and in the inflammatory area of cerebrum (H). The insert in G
is a negative control from the cerebellum of a non-infected animal. Original magnification: A-B, C (insert), D: x400; C: x200; E-F: x100; G (insert)-H,
x1000.
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neutrophil-dependent mechanisms [25]. It is highly
expressed in sera of dengue fever and dengue hemorrha-
gic fever patients, as well as in in vitro models of DENV
infection [26,27]. In the lethal encephalitis induced by
the JHM strain of mouse hepatitis virus (JHMV), neu-
trophils enter the CNS at least 24 h before other infil-
trating mononuclear cells and remain the dominant
inflammatory cell population throughout infection.
Infection with JHMV in neutropenic animals results in
increased levels of virus replication and mortality.
Furthermore, neutropenia is associated with reduced
infiltration of all inflammatory cells, showing that neu-
trophils play a key role in promoting infiltration of
mononuclear inflammatory cell populations in response
to CNS viral infection [28]. A paradoxical role for
Figure 5 Pathology scores for the brain after DENV-3 infection (C). Morphological analysis was performed on coded samples of different
brain areas (cerebrum, cerebellum, hippocampus, brainstem and meninges) at 3 and 6 days p.i. These show progressive pathological changes
after DENV-3 infection. Horizontal bars represent median scores.
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W N V[ 2 9 ] .N e u t r o p h i l sh a v eab i p h a s i cr o l ei nW N V
infection, serving as a reservoir for replication and disse-
mination in early infection and later contributing to
viral clearance. Also, the immune response to dengue
virus may involve cell infiltration at two moments, since
neutrophils are visualized in early and late stages of
brain inflammation after DENV-3 infection. Further stu-
dies are needed to dissect the role of neutrophils along
the disease course.
Figure 6 DENV-3 infection induces cytokines (IFN-g and TNF-a) and chemokines (CCL2, CCL5, CXCL1, CXCL2) in brain of control mice
and of mice infected by the intracranial route with 4 × 10
3 PFU of DENV-3 (n = 9, for each time point). Infected mice exhibit high levels
of cytokines and chemokines during infection when compared with control animals. Data expressed as mean ± SEM. ***p < 0.001, **p < 0.01, *p
< 0.05.
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of CCL2, CCL5, CXCL1, as well as of the cytokines TNF-
a and IFN-g, at 6 days p.i. The production of these pro-
teins possibly created a more favorable milieu for cell
migration and may themselves be produced by migrated
cells. The early and late expression of CXCL1 and
CXCL2 suggests that there is a continuous recruitment
of neutrophils to the brain, which was confirmed by his-
topathology, MPO and FACS results. CCL5 is a member
of the CC chemokine family and recruits monocytes and
T cells via the chemokine receptors CCR1, CCR3, and
CCR5. CCL5 has also been reported to be up-regulated
during dengue infection [30]. We recently demonstrated
that CCR1, CCR2 and CCR4 have minor effects in the
pathogenesis of disease in a model of DENV-2 in mice
inoculated by i.p. route. It appears that these receptors
do not play an essential role in protection against pri-
mary infection, suggesting that the chemokine storm that
follows severe primary dengue infection correlates pri-
marily with development of disease rather than protec-
tion against severe infection [31].
We found increased levels of TNF-a in mouse brain
tissue just before the onset of clinical signs of encephali-
tis. It is well known that higher concentrations of TNF-
a correlate with severe dengue disease in vivo and high
viral titers in vitro and in vivo [32]. Higher levels of
TNF-a in infected mice have been associated with
endothelial activation [33,34]. During viral encephalitis,
MMPs can affect inflammatory responses by processing
molecules like TNF-a, mediating transmigration of leu-
kocytes and the development of CNS damage [13]. In
DENV-3 infected mice, enhanced levels of TNF-a may
reflect activation of endothelial cells, which in turn leads
to an increase in the number of rolling and adhered leu-
kocytes seen by intravital microscopy. These results are
in accordance with in vitro studies that have demon-
strated TNF-a up-regulation of polymorphonuclear cell
adhesion to cerebral endothelium [35]. Increased levels
of TNF-a m a ya l s ob ei n v o l v e di nt h eb e h a v i o r a ls i g n s
detected on day 6 p.i. The cytokines IL-1-b,I L - 6 ,a n d
TNF-a have been associated with cognitive processes
such as synaptic plasticity, neurogenesis, and neuromo-
dulation [36].
Another important cytokine up-regulated in DENV-3
infected mice was IFN-g.I F N - g plays a crucial role in
the ability of the murine host to deal with dengue infec-
tion. High levels of IFN-g are observed in patients with
dengue and are associated with severity of the disease
[37,38]. Dengue hemorrhagic fever induced by DENV-3
has been associated with higher viremia early in illness
and earlier peak plasma IFN-g levels; maximum plasma
viremia levels correlate with degree of plasma leakage
and thrombocytopenia [39]. Some researchers have
Figure 8 Brain-sequestered cell numbers in C57Bl/6 mice of control mice (n = 6) and of mice infected with DENV-3. C57Bl/6 mice were
infected with 4 × 10
3 PFU of DENV-3 by the intracranial route, and assessed at days 3 (n = 4) and 6 p.i. (n = 4). Brain-sequestered cells were
counted and then stained with specific antibodies. Flow cytometry, with assessment according to size and granularity, was performed as analysis.
Numbers of neutrophils (A), and CD4
+ (B) and CD8
+ (C) T lymphocytes were evaluated in WT mice. Results are expressed as mean ± SEM, and
*p < 0.05, ***p < 0.001 when compared to non-infected mice. ###p < 0.001 when compared to 3 p.i. infected mice.
Figure 7 MPO levels in cerebral tissue of control mice and
mice infected by the intracranial route with 4 × 10
3 PFU of
DENV-3. Infected mice showed increased NAG levels on day 6,
when compared with the control mice. Data represent results from
groups of at least five mice, and results are expressed as mean ±
SEM. ***p < 0.001; **p < 0.01.
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tible to dengue infection [40]. We have previously
detected high levels of IFN-g,t o g e t h e rw i t hI L - 6a n d
CCL2, in brain homogenates and sera of mice infected
with DENV-3 genotype I, confirming its virulence and
immunogenicity in the brain [41]. The secretion of the
cytokine IFN-g by CD8
+ T-cells plays a role in the
defense against DENV-2 [42]. We also observed a pro-
gressive increase of IFN-g associated with high numbers
of CD8
+ T-cells in brain tissue, showing also the impor-
tance of this cytokine during infection with DENV-3.
Some experimental studies have provided evidence that
glucocorticoid treatment can have beneficial effects, but
this may also exacerbate the pathogenesis of viral ence-
phalitis. The use of glucocorticoids during viral ence-
phalitis can restrain inflammation and microglial
reactivity, and decrease cerebral damage due to viral
replication. However, such therapy initiated before the
establishment of an appropriate acute-phase response
may increase neurovirulence and CNS damage [43].
Other cytokines may also be involved in the pathogen-
esis of DENV-3 infection. IFN type I (a/b), which is
produced by many cells, is crucial for the immediate
control of initial viral replication and powerfully initiates
innate and specific immune responses [44]. Studies with
mice infected with DENV-2 by intravenous route have
demonstrated that IFN-a/b receptor-mediated action
limits initial virus replication in extraneural sites and
controls subsequent viral spread into the CNS. In con-
trast, IFN-g receptor-mediated responses seem to act at
later stages of dengue disease by restricting viral replica-
tion in the periphery and eliminating virus from the
CNS [45]. The mechanisms by which the IFN system
mediates the antiviral response in mice after intracranial
inoculation with DENV-3 have not yet been elucidated.
Further experiments are necessary to clarify the role of
IFNs during meningoencephalitis caused by DENV.
In conclusion, the present study shows that neuroin-
flammatory changes lead to alterations in motor beha-
vior and muscle tone and strength in DENV-3-infected
mice. The neuroinflammatory process is marked by
up-regulation of the chemokines CCL2, CCL5, CXCL1,
and CXCL2, and of the cytokines TNF-a and IFN-g,
which occurs in parallel with increased leukocyte rolling
and adhesion in meningeal vessels and infiltration of
immune cells into the brain. The inflammatory response
may play a key role in the development of severe neuro-
logical manifestations in dengue disease.
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